8. Cardiovascular Disease and Risk Management

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Aram V. Chobanian · JAMA · 2003 · 25.6K citations

Medicine, Cardiology, Geriatric Medicine +17

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Joep Perk, Guy De Backer, H. Gohlke et al. · European Heart Journal · 2012 · 8.5K citations · Full text

Medicine, Cardiology, Preventive Medicine +16

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

Paul A. James, Suzanne Oparil, Barry L. Carter et al. · JAMA · 2013 · 8K citations

Medicine, Cardiology, Pharmacotherapy +17

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

JAMA · 2002 · 5.7K citations

Medicine, Cardiology, Pharmacology +14